dr. borghaei on the current landscape of immunotherapy in nsclc
Published 5 years ago • 69 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
0:18
copy of dr. borghaei on the current landscape of immunotherapy in nsclc
-
1:11
dr. borghaei on immunotherapy versus chemotherapy and immunotherapy in nsclc
-
1:37
dr. borghaei on anticipated trials evaluating immunotherapy in nsclc
-
2:33
immunotherapy for lung cancer: current landscape and challenges
-
9:17
the emerging landscape of immunotherapy in nsclc
-
1:36
dr. borghaei on the search for biomarkers in lung cancer
-
1:41
dr. borghaei on reporting immunotherapy-related aes in lung cancer
-
1:54
the evolving landscape of immunotherapy in nsclc
-
2:05
dr. borghaei on the management of immune-related side effects in lung cancer
-
2:02
dr. borghaei on emerging biomarkers in nsclc
-
2:17
dr. borghaei on the checkmate-227 trial in nsclc
-
1:29
dr. borghaei on the clinical utility of pd-l1 in advanced nsclc
-
3:16
a changing treatment landscape in advanced lung cancer
-
1:36
dr. rudin on expansion of immunotherapy in lung cancer
-
1:02
dr. borghaei on immune-related adverse events in lung cancer
-
1:33
dr. borghaei on the fda approval of nivolumab in small cell lung cancer
-
1:59
dr. herbst on key immunotherapy findings in nsclc
-
1:14
dr. brahmer on immunotherapy in stage iv nsclc
-
50:45
dr. hossein borghaei: immunotherapy & small cell lung cancer